 Anti-HIV Agents
"Anti-HIV Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.
| Descriptor ID |
D019380
|
| MeSH Number(s) |
D27.505.954.122.388.077.088
|
| Concept/Terms |
Anti-HIV Agents- Anti-HIV Agents
- Agents, Anti-HIV
- Anti HIV Agents
- Anti-HIV Drugs
- Anti HIV Drugs
- Drugs, Anti-HIV
- AIDS Drugs
- Drugs, AIDS
- Anti-AIDS Agents
- Agents, Anti-AIDS
- Anti AIDS Agents
- Anti-AIDS Drugs
- Anti AIDS Drugs
- Drugs, Anti-AIDS
|
Below are MeSH descriptors whose meaning is more general than "Anti-HIV Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-HIV Agents".
This graph shows the total number of publications written about "Anti-HIV Agents" by people in UAMS Profiles by year, and whether "Anti-HIV Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2025 | 1 | 0 | 1 | | 2024 | 0 | 2 | 2 | | 2022 | 2 | 0 | 2 | | 2021 | 3 | 0 | 3 | | 2020 | 1 | 1 | 2 | | 2019 | 0 | 1 | 1 | | 2018 | 1 | 0 | 1 | | 2016 | 1 | 0 | 1 | | 2015 | 0 | 1 | 1 | | 2014 | 1 | 1 | 2 | | 2013 | 3 | 2 | 5 | | 2012 | 2 | 0 | 2 | | 2011 | 2 | 0 | 2 | | 2010 | 3 | 0 | 3 | | 2009 | 2 | 0 | 2 | | 2008 | 1 | 0 | 1 | | 2007 | 2 | 2 | 4 | | 2006 | 1 | 0 | 1 | | 2003 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-HIV Agents" by people in Profiles over the past ten years.
-
Yanamadala Y, Muthumula CMR, Gokulan K, Karn K, Sutherland V, Cunny H, Santos JH, Khare S. Gestational exposure to HIV drugs alters intestinal mucosa-associated microbial diversity in adult rat offspring. Exp Biol Med (Maywood). 2025; 250:10564.
-
Horton H, Marshall SA, Gu M, Tody B, Jackson T, Zaller N. Randomized controlled trial of a pilot PrEP linkage intervention for individuals leaving incarceration in a southern state: Design and baseline characteristics. PLoS One. 2024; 19(12):e0312667.
-
Tao J, Parent H, Karki I, Martin H, Marshall SA, Kapadia J, Nunn AS, Marshall BDL, Raymond HF, Mena L, Chan PA. Perspectives on a peer-driven intervention to promote pre-exposure prophylaxis (PrEP) uptake among men who have sex with men in southern New England: a qualitative study. BMC Health Serv Res. 2024 Sep 04; 24(1):1023.
-
Kirmse B, Hobbs C, Aaron L, Montepiedra G, Summar M, Williams PL, Smith CJ, Van Dyke R, Yu C, Ryckman KK, Borkowsky W. Acylcarnitines and Genetic Variation in Fat Oxidation Genes in HIV-infected, Antiretroviral-treated Children With and Without Myopathy. Pediatr Infect Dis J. 2022 08 01; 41(8):e306-e311.
-
Marshall SA, Barham C, Neher T, Zielinski MJ, Brinkley-Rubinstein L, Gorvine MM, Zaller N. Acceptability of a Community Health Worker Program to Link High-Risk People in Jail to HIV Pre-Exposure Prophylaxis. J Health Care Poor Underserved. 2022; 33(1):149-166.
-
Vijayan V, Naeem F, Veesenmeyer AF. Management of Infants Born to Mothers with HIV Infection. Am Fam Physician. 2021 07 01; 104(1):58-62.
-
Walker CK, Shaw CM, Moss Perry MV, Claborn MK. Antiretroviral Therapy Management in Adults With HIV During ICU Admission. J Pharm Pract. 2022 Dec; 35(6):952-962.
-
Whiteside-Mansell L, Sockwell L, Knight D, Crone C. Community Legal Systems: Targeting PrEP and HIV Education to Decrease Risk of HIV Transmission. AIDS Behav. 2021 Aug; 25(8):2578-2590.
-
Ramos JC, Sparano JA, Chadburn A, Reid EG, Ambinder RF, Siegel ER, Moore PC, Rubinstein PG, Durand CM, Cesarman E, Aboulafia D, Baiocchi R, Ratner L, Kaplan L, Capoferri AA, Lee JY, Mitsuyasu R, Noy A. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 2020 09 10; 136(11):1284-1297.
-
Callen AL, Dupont SM, Pyne J, Talbott J, Tien P, Calabrese E, Saloner D, Chow FC, Narvid J. The regional pattern of abnormal cerebrovascular reactivity in HIV-infected, virally suppressed women. J Neurovirol. 2020 10; 26(5):734-742.
-
Kelly MS, Zheng J, Boiditswe S, Steenhoff AP, Feemster KA, Arscott-Mills T, Seme B, Ratshaa B, Rulaganyang I, Patel MZ, Mantzor S, Shah SS, Cunningham CK. Investigating Mediators of the Poor Pneumonia Outcomes of Human Immunodeficiency Virus-Exposed but Uninfected Children. J Pediatric Infect Dis Soc. 2019 Mar 28; 8(1):13-20.
-
Hobbs CV, Gabriel EE, Kamthunzi P, Tegha G, Tauzie J, Li Y, Ilmet T, Artimovich E, Neal J, Hall T, Parikh S, Kirmse B, Jean-Philippe P, Chen J, Prescott WR, Palumbo P, Duffy PE, Borkowsky W. Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy. Am J Trop Med Hyg. 2018 01; 98(1):67-70.
-
Kirmse B, Yao TJ, Hofherr S, Kacanek D, Williams PL, Hobbs CV, Hazra R, Borkowsky W, Van Dyke RB, Summar M. Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States. AIDS Res Hum Retroviruses. 2016 Apr; 32(4):339-48.
-
Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R, Baiocchi R, Dezube BJ, Henry D, Kaplan L, Levine AM, Mitsuyasu R, Ratner L, Reid E, Remick S, Sparano J, Tzachanis D, Wachsman W, Chadburn A. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leuk Lymphoma. 2016 07; 57(7):1731-4.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|